This item is part of Stockwatch's value added news feed and is only available to Stockwatch subscribers.
Here is a sample of this item:
by Stockwatch Business Reporter
The S&P/TSX Cannabis Index added 1.82 to 225.37, while the CSE Composite Index lost 7.05 to 788.58. South of the border, Washington State is counting on cannabis to boost COVID-19 vaccination rates. The state's Liquor and Cannabis Board has unveiled a temporary "Joints for Jabs" promotion whereby cannabis retailers may provide one free preroll to adults who get their first or second shot at an in-store vaccination clinic. This follows the board's previous allowance for free beer, wine or cocktails. Across the United States, regulators and retailers have been dangling everything from groceries to sports tickets to cold, hard cash (arguably providing as much of an incentive to get a shot as an incentive to wait and see what freebies come next). Alas for those good citizens who got their shots purely because it was the right thing to do, they have mostly missed out on the showers of gifts. Maybe next pandemic.
Within the U.S. cannabis sector, MSO (multistate operator) Vireo Health International Inc. (VREO) added 10 cents to $2.91 on 371,800 shares, after announcing a rebranding. It plans to change its name to Goodness Growth Holdings Inc., effective tomorrow. Its new symbol will be GDNS.
The remainder is available to Stockwatch subscribers.
© 2021 Canjex Publishing Ltd. All rights reserved.